ENT & Otolaryngology
ENT practices and management organizations providing surgical and medical care for ear, nose, and throat conditions.
- 6
- Verticals
Overview
ENT & Otolaryngology covers practices and management organizations providing surgical and medical care for ear, nose, and throat conditions. It is an emerging specialty roll-up, with ancillary economics (allergy, audiology, imaging, in-office procedures, ASCs) attracting private equity.
PE-backed ENT platforms (SENTA, Specialty Networks) have begun consolidating practices and their ancillaries. Demand is supported by chronic ENT conditions, allergy, and hearing care, plus the migration of procedures to office and ASC settings.
Market snapshot
Within Offices of Physicians (NAICS 621111); the Census Bureau does not split physician offices by specialty, so ENT is not separately sized.
Business model & economics
Revenue model
Office, surgical, and ancillary reimbursement
Key economics
- Recurring revenue
- Moderate
- EBITDA margin
- 18–28% with ancillaries
- Capex intensity
- Moderate
chronic and recurring care
Characteristics
- Emerging specialty roll-up.
- Allergy, audiology, and procedural ancillaries.
- Procedure migration to office and ASC settings.
M&A deal context
Who’s acquiring
- PE-backed ENT platforms
- Specialty MSO consolidators
- Multispecialty acquirers
What’s driving deals
- Emerging ENT roll-up for ancillaries.
- Allergy and hearing-care demand.
- Office/ASC procedure migration.
Verticals in this segment
Find ENT & Otolaryngology acquisition targets
Search Acquisera’s index for companies classified under ENT & Otolaryngology (4.10.9) and build a targeted deal pipeline.
Search companies